```html

Dermatitis (Eczema) – A Complete Patient‑Friendly Guide

Overview

Dermatitis, most commonly referred to as eczema, is a group of inflammatory skin conditions that cause intense itching, redness, and sometimes oozing or crusting. The term “eczema” is often used interchangeably with “atopic dermatitis,” which is the most prevalent form, but other types include contact dermatitis, dyshidrotic eczema, nummular eczema, and seborrheic dermatitis.

Who it affects

• Children – up to 20% of children worldwide develop atopic dermatitis before the age of five. [1] CDC, 2023
• Adults – about 3%–10% of adults have persistent or adult‑onset eczema. [2] Mayo Clinic, 2024
• Both sexes are equally affected, though some studies suggest a slightly higher prevalence in females after puberty. [3] WHO, 2022

Prevalence

• Worldwide prevalence ranges from 5% to 20% in children and 2% to 7% in adults. [4] NIH, 2023
• In the United States, an estimated 31.4 million people (≈9.5% of the population) reported eczema in the past year. [5] CDC, 2022

Symptoms

Eczema can manifest differently depending on the type, age, and body region involved. The following list covers the most common signs and their typical presentation.

General Symptoms (All Types)

• Itching (pruritus) – usually the first and most distressing symptom; scratching can worsen inflammation.
• Red, inflamed patches – may be flat (macular) or raised (papular).
• Dry, scaly skin – due to impaired barrier function and loss of natural moisturizing factors.
• Weeping or crusting – in acute flares, skin may ooze clear fluid that later forms a crust.
• Thickened, leathery skin (lichenification) – chronic scratching leads to skin thickening.
• Hyperpigmentation or hypopigmentation – skin color changes after healing.

Age‑Specific Presentation

• Infants (0‑2 years) – facial and scalp involvement, especially on cheeks, forehead, and scalp; the “cradle cap” appearance.
• Children (2‑12 years) – flexural areas (inside elbows, behind knees) are classic sites; may also affect the neck, wrists, and ankles.
• Adults – flexural sites still common, but hand, foot, and eyelid involvement become more frequent; nummular (coin‑shaped) lesions are seen.

Special Forms

• Contact dermatitis – localized rash directly over the area of contact with an irritant or allergen; may be acute (red, blistery) or chronic (dry, fissured).
• Dyshidrotic eczema – small, intensely itchy vesicles on the sides of the fingers, palms, or soles.
• Nummular eczema – round or oval plaques, often oozing, typically on the arms or legs.
• Seborrheic dermatitis – greasy, yellowish scales on the scalp, eyebrows, or nasolabial folds; may coexist with atopic eczema.

Causes and Risk Factors

Eczema is multifactorial – genetics, immune dysregulation, skin barrier defects, and environmental triggers all play a role.

Genetic Factors

• Mutations in the FLG gene (filaggrin) impair the skin’s barrier, increasing water loss and allergen penetration. [6] Cleveland Clinic, 2023
• Family history of atopic disease (eczema, asthma, allergic rhinitis) raises risk 3‑5‑fold. [7] NIH, 2022

Immune System Abnormalities

• Elevated Th2‑type cytokines (IL‑4, IL‑13) drive inflammation and IgE production.
• Skin microbiome shifts – overgrowth of Staphylococcus aureus can aggravate flares. [8] JAMA Dermatology, 2021

Environmental & Lifestyle Triggers

• Irritants: harsh soaps, detergents, wool, synthetic fabrics.
• Allergens: nickel, latex, fragrances, certain foods (especially in infants).
• Climate: low humidity, extreme temperatures, and frequent sweating.
• Stress: emotional or psychological stress can precipitate flares.
• Infections: viral (e.g., herpes simplex), bacterial (e.g., impetigo), or fungal infections can exacerbate eczema.

Who Is at Higher Risk?

• Infants with a parent or sibling who has eczema, asthma, or hay fever.
• People living in urban areas with higher pollution levels.
• Individuals with a personal history of food allergies, especially to eggs, milk, peanuts, or wheat.
• Patients with compromised skin barrier (e.g., frequent hand washing, occupational exposure).

Diagnosis

Diagnosing eczema is primarily clinical, based on history and visual examination. No single laboratory test confirms the condition, but certain investigations help rule out mimickers or identify contributing factors.

Clinical Assessment

• History taking – onset age, pattern of lesions, family history of atopy, known triggers, and previous treatments.
• Physical exam – distribution, morphology, and chronic changes (lichenification, excoriations).
• Use of validated tools such as the SCORAD (SCORing Atopic Dermatitis) index to grade severity. [9] WHO, 2022

When Additional Tests Are Helpful

• Patch testing – identifies specific contact allergens in suspected allergic contact dermatitis.
• Skin scraping or swab – cultures for bacterial (e.g., S. aureus) or fungal infection when infection is suspected.
• Blood work – total IgE levels may be elevated but are not diagnostic; eosinophil count can support an atopic picture.
• Skin biopsy – rarely needed; reserved for atypical presentations or when ruling out conditions such as psoriasis or cutaneous lymphoma.

Treatment Options

The goal of therapy is to control symptoms, restore the skin barrier, and prevent flares. Treatment is usually stepped according to severity (mild, moderate, severe).

1. Skincare & Barrier Repair (Foundational)

• Emollients/moisturizers – apply liberally at least twice daily; ointments (petrolatum, mineral oil) are more effective than creams for severe dryness.
• Barrier creams – contain dimethicone or ceramides; useful for hands and areas exposed to irritants.
• Bathing practices – lukewarm baths for 10‑15 minutes, followed by immediate moisturization (“the soak‑and‑seal method”).

2. Topical Medications

• Corticosteroids – first‑line for active flares. Choose potency based on location (low‑potency for face/children, medium‑high for trunk/extremities). [10] Mayo Clinic, 2024
• Topical Calcineurin Inhibitors (tacrolimus 0.03%/0.1%, pimecrolimus 1%) – steroid‑sparing agents, safe for delicate skin.
• Phosphodiesterase‑4 inhibitor – crisaborole 2% ointment approved for mild‑to‑moderate eczema.
• JAK inhibitors – topical ruxolitinib 1.5% cream, newer agents for patients not responding to steroids.

3. Systemic Therapies (Moderate‑Severe or Refractory)

• Oral corticosteroids – short bursts for severe acute flares; not recommended for long‑term use due to side effects.
• Dupilumab – monoclonal antibody targeting IL‑4Rα; first biologic approved for moderate‑to‑severe atopic dermatitis. Improves itch and skin clearance. [11] NIH, 2023
• Other biologics/JAK inhibitors – tralokinumab, baricitinib, upadacitinib – emerging options for patients who cannot use dupilumab.
• Cyclosporine, methotrexate, azathioprine – traditional immunosuppressants used in select refractory cases under close monitoring.

4. Adjunctive Measures

• Antihistamines – especially sedating agents at night to reduce scratching.
• Wet wrap therapy – apply topical medication, then a damp layer of clothing, followed by a dry layer; enhances penetration and hydrates skin.
• Phototherapy – narrow‑band UVB or excimer laser for patients unresponsive to topical/systemic meds.

5. Infection Management

• Topical antibiotics (mupirocin) for localized bacterial infection.
• Oral antibiotics (e.g., cephalexin) for extensive cellulitis or impetigo.
• Antifungal creams for secondary Candida or tinea infection.

Living with Dermatitis (eczema)

Beyond medication, everyday habits dramatically influence disease control.

Daily Skincare Routine

1. Moisturize immediately after bathing while skin is still damp.
2. Use fragrance‑free, dye‑free cleansers; avoid traditional “antibacterial” soaps.
3. Apply emollient at least twice daily, more often if skin feels tight.

Clothing & Environment

• Wear soft, breathable fabrics (cotton, bamboo). Avoid wool, polyester, and tight cuffs.
• Keep indoor humidity between 40%‑60%; use a humidifier in dry climates.
• Maintain a moderate, stable temperature; over‑heating triggers sweating and itching.

Itch‑Control Strategies

• Keep nails short; consider wearing cotton gloves at night.
• Apply a cool compress or take a lukewarm shower when itch spikes.
• Incorporate stress‑reduction techniques (mindfulness, yoga, breathing exercises).

Trigger Identification & Avoidance

• Keep a symptom diary to link flares with foods, products, or activities.
• Patch test if contact allergens are suspected.
• Limit exposure to known irritants (e.g., cleaning agents) and wear protective gloves with a cotton liner.

Nutrition & Lifestyle

• Maintain a balanced diet rich in omega‑3 fatty acids (fatty fish, flaxseed) – some evidence suggests modest benefit.
• Stay well‑hydrated; water supports skin barrier function.
• Regular moderate exercise improves circulation and stress levels, but shower promptly afterward to remove sweat.

Prevention

While eczema may have a genetic predisposition, many steps can reduce the frequency and severity of flares.

• Early moisturization – start emollient therapy within weeks of the first rash, especially in infants at high risk.
• Avoid known irritants – choose fragrance‑free detergents, hypoallergenic skin‑care products.
• Protect the skin barrier – wear gloves for dishwashing or housecleaning; apply barrier cream before exposure.
• Vaccinations – keep up to date; some infections (e.g., measles) can precipitate severe eczema.
• Breastfeeding – exclusive breastfeeding for the first 4‑6 months is associated with lower eczema rates in several studies. [12] WHO, 2021
• Allergy assessment – early evaluation for food allergies in infants with severe eczema may prevent later exacerbations.

Complications

If eczema is poorly controlled, several complications can arise:

• Secondary skin infection – bacterial (most commonly S. aureus), viral (eczema herpeticum), or fungal; can lead to cellulitis or systemic infection.
• Sleep disturbance – chronic itching disrupts sleep, affecting quality of life and mental health.
• Psychological impact – increased rates of anxiety, depression, and attention‑deficit disorders, particularly in children. [13] JAMA Psychiatry, 2020
• Hand dermatitis – occupational exposure (healthcare, cleaning) can cause chronic, painful eczema affecting work.
• Skin thickening and scarring – repeated scratching may cause permanent lichenification or disfiguring scars.

When to Seek Emergency Care

---

For personalized advice, always consult a dermatologist or primary‑care provider. This guide is for educational purposes and does not replace professional medical evaluation.

References

1. Centers for Disease Control and Prevention (CDC). “Atopic Dermatitis Data and Statistics.” 2023.
2. Mayo Clinic. “Eczema (Atopic Dermatitis) Overview.” Updated 2024.
3. World Health Organization (WHO). “Global Prevalence of Skin Diseases.” 2022.
4. National Institutes of Health (NIH). “Eczema Fact Sheet.” 2023.
5. CDC. “National Health Interview Survey: Eczema Prevalence, 2022.”
6. Cleveland Clinic. “Filaggrin Gene and Skin Barrier.” 2023.
7. NIH. “Atopic March and Family History.” 2022.
8. JAMA Dermatology. “Staphylococcus aureus Colonization in Atopic Dermatitis.” 2021.
9. World Health Organization. “SCORAD Index for Atopic Dermatitis.” 2022.
10. Mayo Clinic. “Topical Corticosteroids: How to Use Them Safely.” 2024.
11. National Institutes of Health. “Dupilumab for Atopic Dermatitis.” 2023.
12. World Health Organization. “Breastfeeding and Atopic Dermatitis.” 2021.
13. JAMA Psychiatry. “Psychiatric Comorbidities in Children with Eczema.” 2020.

```